Article
Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients.
The Journal of experimental medicine - 7 Mar 2005
Muraro Paolo A, Douek Daniel C, Packer Amy, Chung Katherine, Guenaga Francisco J, Cassiani-Ingoni Riccardo, Campbell Catherine, Memon Sarfraz, Nagle James W, Hakim Frances T, Gress Ronald E, McFarland Henry F, Burt Richard K, Martin Roland
Abstract excerpt
Clinical trials have indicated that autologous hematopoietic stem cell transplantation (HSCT) can persistently suppress inflammatory disease activity in a subset of patients with severe multiple sclerosis (MS), but the mechanism has remained unclear. To understand whether the beneficial effects on the course of disease are mediated by lympho-depletive effects alone or are sustained by a regeneration of the immune...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
